Infectious Diseases Clinical Trials Network (IDCTN)

Background
The National Institute of Allergy and Infectious Diseases (NIAID) aims to advance its mission by supporting a cooperative network for the rapid implementation of clinical trials that align with NIH and NIAID priorities. This initiative is designed to address public health needs through the evaluation of therapeutics, vaccines, biologics, diagnostics, and devices targeting infectious diseases, including emerging and chronic infections.

The network consists of Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), which together provide the necessary infrastructure and administrative framework for conducting clinical trials efficiently.

Grant Details
The grant supports the establishment of a cooperative network that includes Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC). The CTEUs are responsible for implementing clinical trials and studies, while the NCC collaborates with CTEU leaders to provide organizational support, engage experts in generating innovative concepts for public health advancements, and mentor future clinical trialists.

The grant will facilitate the evaluation of various medical interventions targeting infectious diseases.

Eligibility Requirements
Eligible applicants include institutions or organizations capable of conducting clinical trials in alignment with NIAID's mission. There may be preferences for those with prior experience in infectious disease research or clinical trial management.

Period of Performance
The period of performance for this grant opportunity is expected to align with the timelines necessary to address urgent public health needs.

Grant Value
The total value of the grant opportunity has not been specified in the provided text. However, it is implied that funding will be allocated based on the scope and requirements of the proposed clinical trials.